Affluent Medical SA (FR:AFME) has released an update.
Affluent Medical, a French MedTech company specializing in minimally invasive implants for structural heart diseases and urinary incontinence, announced its share capital and voting rights as of May 30, 2024. The company, which has all devices in clinical studies, shared its number of shares and voting rights, with a goal to commercialize its products from early 2026, pending positive clinical results and necessary financing.
For further insights into FR:AFME stock, check out TipRanks’ Stock Analysis page.
